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Abstract
Congenital hearing loss affects 1 in every 1000 births, with genetic mutations contributing to
more than 50% of all cases. X-linked nonsyndromic hereditary hearing loss is associated
with six loci (DFNX1-6) and five genes. Recently, the missense mutation (c.1771G>A, p.
Gly591Ser) in COL4A6, encoding the basement membrane (BM) collagen α6(IV) chain,
was shown to be associated with X-linked congenital nonsyndromic hearing loss with
cochlear malformation. However, the mechanism by which the COL4A6 mutation impacts
hereditary hearing loss has not yet been elucidated. Herein, we investigated Col4a6 knock-
out (KO) effects on hearing function and cochlear formation in mice. Immunohistochemistry
showed that the collagen α6(IV) chain was distributed throughout the mouse cochlea within
subepithelial BMs underlying the interdental cells, inner sulcus cells, basilar membrane,
outer sulcus cells, root cells, Reissner’s membrane, and perivascular BMs in the spiral lim-
bus, spiral ligament, and stria vascularis. However, the click-evoked auditory brainstem
response analysis did not show significant changes in the hearing threshold of Col4a6 KO
mice compared with wild-type (WT) mice with the same genetic background. In addition, the
cochlear structures of Col4a6 KO mice did not exhibit morphological alterations, according
to the results of high-resolution micro-computed tomography and histology. Hence, loss of
Col4a6 gene expression in mice showed normal click ABR thresholds and normal cochlear
formation, which differs from humans with the COL4A6 missense mutation c.1771G>A, p.
Gly591Ser. Therefore, the deleterious effects in the auditory system caused by the mis-
sense mutation in COL4A6 are likely due to the dominant-negative effects of the α6(IV)
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chain and/or α5α6α5(IV) heterotrimer with an aberrant structure that would not occur in
cases with loss of gene expression.
Introduction
The ear, a precise organ composed of the external, middle, and inner ear, that is heavily
involved in the auditory system and balance. Auditory function plays an important role in
communication and learning abilities [1]. The process of hearing begins when sound is con-
ducted by air or bone. During air conduction, sound waves are collected, causing vibration of
the tympanic membrane and ossicular chain. Sound waves also transfer through the skull,
which is referred to as bone conduction. Vibrations within the endolymph through stapedial
vibrations stimulate auditory receptors in the cochlea.
The cochlea, comprising the modiolus and osseous cochlear duct, is a spiral-shaped cavity
in the bony labyrinth. The membranous cochlear duct is located in the osseous cochlear duct
and includes the spiral limbus, basilar membrane, organ of Corti, and stria vascularis in the
spiral ligament, which contribute to the mechanical-electrical signal conversion and ion trans-
portation during sound conduction [1, 2]. The extracellular matrix (ECM) also contributes to
the auditory system; collagen and cochlin are the most abundant ECM components in the
cochlea. Fibrillar collagen primarily provides tissue stability and strength, while cochlin inter-
acts with collagen molecules [3]. Interestingly, a recent study has shown that cochlin also plays
a role in innate immune responses within the inner ear [4]. Histologically, basement mem-
branes (BMs) are present in the membranous labyrinth of the cochlea. The BM is a cell-adher-
ent and sheet-like ECM found beneath the epithelium and endothelium, and surrounding
smooth muscle cells, and adipocytes. The primary role of BMs is to provide tissue structure,
divide the tissue into compartments, and influence cell behavior [5]. Collagen IV, laminin, per-
lecan, and nidogen are major components of BMs. Collagen IV comprises six genetically dis-
tinct α chains from α1(IV) to α6(IV) encoded by COL4A1 to COL4A6. Three unique triple-
helical forms have been identified: α1α2α1, α3α4α5, and α5α6α5 (Fig 1). Furthermore, these
protomers are extracellularly assembled into three hexamers, namely, α1α2α1-α1α2α1,
α1α2α1-α5α6α5, and α3α4α5-α3α4α5 [6–8]. Previous reports showed that α1(IV) and α2(IV)
chains are abundant in all BMs, whereas α3(IV) to α6(IV) chains have a tissue-specific distri-
bution. It is believed that the differential molecular composition of BM contributes to its spe-
cific biological roles in tissues. Specifically, the α6(IV) chain is preferentially found in
subepithelial- and smooth muscle cell-BMs in various organs [9–15].
Various genes encoding ECM or ECM-related proteins reportedly cause hereditary hearing
loss, including COL4A6, which encodes the sixth alpha chain of collagen IV [16, 17]. Previ-
ously, we established Col4a6 knockout (KO) mice, which are apparently healthy and fertile,
but show a developmental delay in keratinization of the oral mucosal epithelium [18–20]. In
zebrafish, col4a5 and col4a6 are essential for BM integrity, supporting the axogenesis of gran-
ule cells and retinal ganglion cells [21]. Thus, the collagen α6(IV) chain is a crucial element of
BMs; however, its physiological role remains elusive.
Recently, the missense mutation (c.1771G>A, p.Gly591Ser) in COL4A6 was reported to be
associated with X-linked congenital nonsyndromic hearing loss with cochlear malformation
(OMIM: #300914); indeed, all the male subjects in this family experienced severe-to-profound
hearing loss at all frequencies tested (0.125 to 8 kHz). Bioinformatic analysis predicted that the
p.Gly591Ser missense mutation reduces the triple-helical conformational stability and triggers
quaternary structure disassembly [22]. However, the impact of this mutation in the collagen
α6(IV) chain in vivo remains unclear.
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In this study, we investigate the collagen α6(IV) chain distribution in mouse cochlea and its
effects on the cochlear formation and auditory function using a Col4a6 KO mouse model.
Overall, our study demonstrated the detailed distribution of collagen α6(IV) chain in mouse
cochlea and showed that loss of expression of Col4a6 in mice does not cause abnormalities in
the cochlear structure or severe-to-profound hearing loss, which occurs in humans with mis-
sense mutation (c.1771G>A, p.Gly591Ser) of COL4A6.
Materials and methods
Animals
Male Col4a6 KO and WT mice (8-week-old) were used in this study. Col4a6 KO mice were
generated by replacing part of exon 2 and intron 2 with a neomycin cassette in the Col4a6
Fig 1. Schematic view of the gene structure and assembly of collagen IV. The COL4A6/Col4a6 gene is located on the X chromosome and
paired with COL4A5/Col4a5 in a head-to-head manner. COL4A1/Col4a1 and COL4A2/Col4a2, and COL4A3/Col4a3 and COL4A4/Col4a4
pairs are located in a head-to-head manner on their respective chromosomes (not shown). Each chain comprises a 400 nm long triple-helical
domain, which contains many interruptions in the Gly-X-Y repeated sequence. The globular noncollagenous domain (NC1) is located at the
C-terminal end, while the 7S domain is at the N-terminal end. Three α chains assemble the triple-helical molecule (triple-helix). The
heterotrimers extracellularly form a hexamer. α1α2α1(IV) and α5α6α5(IV) bind to each other through the NC1 domain [α1α2α1-α5α6α5
(IV)] and the 7S domains (not shown), which facilitates their assembly to a higher-ordered supra structure. α1α2α1(IV) is widely distributed,
whereas α3α4α5(IV) and α5α6α5(IV) distribution is tissue specific [7–9, 12]. In Col4a6 KO mice, the loss of α6(IV) chain expression inhibits
the formation of the α5α6α5(IV) heterotrimer. This study showed that the phenotypes of the auditory system in Col4a6 KO mice were
distinct from those of individuals with the COL4A6 missense mutation c.1771G>A, p.Gly591Ser. The presence of the mutant protein α6(IV)
chain and/or α5α6α5(IV) may induce deleterious effects on the cochlea. The pathogenesis involved in congenital hearing loss warrants
further investigations.
https://doi.org/10.1371/journal.pone.0249909.g001
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gene in the 129 SV/J background, as previously described, and subsequently backcrossed with
C57BL/6J (Charles River) over ten generations [18, 19].
This study was conducted in strict accordance with the Policy on the Care and Use of Labo-
ratory Animals, Okayama University. The protocol was approved by the Animal Care and Use
Committee of the Okayama University (Protocol Number: OKU-2020035).
Immunohistochemistry
The temporal bone was dissected from the mice (8-week-old) anesthetized with intraperitoneal
xylazine (8 mg/kg) and ketamine (80 mg/kg), and snap-frozen in super Cryoembedding
medium (SECTION-LAB Co. Ltd., Hiroshima, Japan). Then, 6 μm serial cryosections were
prepared using Kawamoto’s film methods, as previously described with some modifications
[20]. Briefly, the sections were fixed with acetone for 20 min followed by treatment with 6 M
urea in 0.1 M glycine-HCl buffer (pH 3.5) to expose the epitope. Subsequently, 1% bovine
serum albumin in phosphate buffered saline was used to block non-specific binding of anti-
bodies for 1 h. The following rat monoclonal antibodies were used: H11 (1:100); H22 (1:100);
fluorescein isothiocyanate labeled-M26 (1:10); 129 (1:100); b42 (1:100); H53 (1:300); and B66
(1:10), recognizing collagen α1(IV), α2(IV), α2(IV), α3(IV), α4(IV), α5(IV), and α6(IV)
chains (generated by Dr. Y Tomono and Y Sado in Shigei Medical Research Institute, Oka-
yama, Japan) [9, 11, 23]. Antibodies against CD31 (1:50, ab28364; Abcam, UK), perlecan
(1:1,000, A7L6; Millipore, Burlington, MA, USA), laminin α1 (1:200, AL-1; Chemicon, Temec-
ula, CA, USA), laminin α2 (1:1,000, 4H8-2; Sigma, Saint Louis, MO, USA), laminin γ1
(1:2,000, A5; Chemicon), and nidogen-1 (1:2,000; kindly gift by Dr. Takako Sasaki, Oita Uni-
versity) were used [24]. For the secondary antibody, Alexa Fluor1 488-conjugated goat anti-
rat IgG (1:1,500; Invitrogen, Carlsbad, CA, USA), Alexa Fluor1 594-conjugated goat anti-rat
IgG (1:1,500; Invitrogen), and Alexa Fluor1 594-conjugated donkey anti-rabbit IgG (1:1,500;
Invitrogen) were used. Nuclei were stained with Hoechst 33258 (2 μM; Polysciences, Warring-
ton, PA, USA). All images were obtained with a KEYENCE BZ-X710 microscope (Keyence,
Osaka, Japan), and processed using BZ-X Analyzer software (Keyence). The experiment was
repeated using three WT and three Col4a6 KO mice.
Auditory function
Auditory function was assessed by click-evoked auditory brainstem response (ABR) as previ-
ously described with minor modifications [25, 26]. Col4a6 KO mice (n = 5) and WT mice
(n = 5) were anesthetized with intraperitoneal xylazine (8 mg/kg) and ketamine (80 mg/kg).
The generation of acoustic stimuli and simultaneous recording of evoked potentials were per-
formed using Tucker Davis Technologies (TDT) ABR system (RA16, PA5, RP2.1, TDT, Gaines-
ville, FL, USA). ABRs were evoked with clicks and the sound stimuli were applied in 5-dB SPL
steps from 90 to 0 dB SPL. The click-ABR threshold was determined as the minimum sound
pressure level at which the click-ABR waveform was visible on the recording monitor.
Statistical analysis
Statistical analysis was performed using Student’s unpaired t-test. The data are presented as
the mean ± standard deviation (SD). P< 0.05 was considered statistically significant.
Micro-tomographic analysis (micro-CT)
The temporal bone was dissected from Col4a6 KO and WT mice (8-week-old) anesthetized
with intraperitoneal xylazine (8 mg/kg) and ketamine (80 mg/kg) and fixed with 10% formalin
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in neutral buffer at 4˚C for 24 h. The samples were analyzed by micro-CT (SkyScan 1174 com-
pact micro-CT, Bruker, Belgium) as described previously with some modifications [27]. Scans
were performed at a resolution of 6.5 μm, after which 1,004 sections were reconstructed to pro-
duce the 3-D image of the petrous portion using SkyScan software (NRecon, CTAn, CTvol,
and CTvox, SkyScan). In addition, to compare the shape and size of the cochlea between WT
and Col4a6 KO mice, DataViewer software was used according to the manufacturer’s protocol
(Bruker). Briefly, we selected the volume of interest (VOI) in a 2-dimensional (2-D) plane with
a clear view of the cochlea using WT scan data as a reference. The software automatically gen-
erated three orthogonal views of the best-matched 2-D image from the scan data of Col4a6 KO
as a target to the reference image. In the 2-D overlay image of WT and Col4a6 KO, the match-
ing degree was automatically represented by a color map based on the intensity of the radiog-
raphy using DataViewer. The analysis was repeated using six cochleae from three mice of each
genotype (WT, n = 3; KO, n = 3).
Hematoxylin and eosin (HE) staining
The temporal bone was dissected from Col4a6 KO and WT mice (8-week-old) anesthetized
with intraperitoneal xylazine (8 mg/kg) and ketamine (80 mg/kg) and fixed in 4% paraformal-
dehyde in 0.1 M phosphate buffer (pH 7.2). After decalcification with 0.5 M EDTA (pH 7.5;
Wako, Japan) for 7 days at room temperature, the cochleae were dehydrated and embedded in
paraffin and 5 μm serial sections were prepared using a microtome (MICROM, HM 335E,
Leica, Wetzlar, Germany). A new hematoxylin solution (Muto Pure Chemicals, Japan) and
pure eosin solution (Muto Pure Chemicals) were used. All images were obtained with a KEY-
ENCE BZ-X710 microscope (Keyence) and processed using BZ-X Analyzer software (Key-
ence). The experiment was repeated using three WT and three Col4a6 KO mice.
Results
Distribution of collagen α6(IV) chain in the mouse cochlea
To examine the distribution of the collagen α6(IV) chain in the mouse cochlea, we performed
immunohistochemistry. Several BMs were found in the cochlea, including the subepithelial
BMs of interdental cells, inner sulcus cells, basilar membrane, outer sulcus cells, root cells, and
Reissner’s membrane; perivascular BMs in the spiral limbus, spiral ligament, and stria vascu-
laris; and perineural BMs in the nerve fasciculus and spiral ganglion [28, 29]. We confirmed
that both collagen α1(IV) and α2(IV) chains were present in all BMs in the mouse cochlea, as
described previously (Fig 2A and S1 Fig) [30]. Results show that the collagen α6(IV) chain was
observed in the subepithelial (Fig 2B–2E) and perivascular BMs (Fig 2B, 2D and 2G–2I), but
not in the perineural BMs (Fig 2B and 2F).
For further characterization, we compared the localization of the collagen α6(IV) chain
with that of the collagen α2(IV) chain using immunohistochemistry. The interdental cells are
oval or round in shape and connect to form a comb-shaped network. The surface of the spiral
limbus beneath the tectorial membrane is covered by flat processes of the interdental cells [31].
Although both the α2(IV) and α6(IV) chains were detected as comb-shaped networks, the
immunoreactivity of α6(IV) chain was higher in the invaginated region than in the superficial
plate of the network (Fig 2I). In the spiral ligament, the α6(IV) chain appeared conspicuously
in the radiated epithelial BMs surrounding the root cells and beneath the outer sulcus cells
compared with the α2(IV) chain (Fig 2G and 2J and S1 Fig). In the stria vascularis, the signal
of the α6(IV) chain colocalized at the outer side of α2(IV) chain-containing BMs, which sur-
round the endothelium and pericytes (Fig 2H and 2K).
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Differential composition of collagen IV networks in the mouse cochlea
We performed immunohistochemistry to investigate the molecular composition of cochlear
BMs using Col4a6 KO and WT mice. In WT mice, collagen α5(IV) chain was distributed in
the subepithelial BMs of interdental cells, inner sulcus cells, basilar membrane, outer sulcus
cells, root cells, and Reissner’s membranes; perivascular BMs in the spiral limbus, spiral liga-
ment, and stria vascularis; and the perineural BMs of the neural fasciculus and spiral ganglion
(Fig 3A and 3D–3F). Based on the results for the collagen α6(IV) chain, α5α6α5 was suggested
to be present in all subepithelial BMs and perivascular BMs in the mouse cochlea (Figs 2 and
3).
Notably, the collagen α5(IV) chain was observed in the subepithelial BMs and perineural
BMs, however, it was scarcely detected in the perivascular BMs of Col4a6 KO mice (Fig 3B and
Fig 2. Distribution of collagen α6(IV) chain in the adult mouse cochlea. Sections were immunostained using
antibodies against collagen α2(IV) (A, I–K: green) and α6(IV) (B–H: green; I–K: red) chains, and CD31 (G, H: red) for
the detection of endothelial cells. Subepithelial BMs and perivascular BMs are indicated by open arrowheads and solid
arrowheads in the insets, respectively (G, J, K). (I) The superficial plate and invaginated region of the interdental cells
network are indicated by open arrows and solid arrows in insets, respectively. (L) Schematic diagram of the
distribution of collagen α6(IV) chain [yellow line: subepithelial BMs; pink line: perivascular BMs]. The negative
control was established by immunostaining with only the secondary antibody and no specific reaction was observed
(S2 Fig). Nuclei were counterstained with Hoechst 33258 (blue). SLim: spiral limbus; B, basilar membrane; SLig, spiral
ligament; SV, stria vascularis; RM, Reissner’s membrane; NF, neural fasciculus; SG, spiral ganglion; IDC, interdental
cells; ISC, inner sulcus cells; OSC, outer sulcus cells; RC, root cells; Cap, capillary. Scale bars = 50 μm. Scale bars in
inset = 10 μm.
https://doi.org/10.1371/journal.pone.0249909.g002
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3G–3I). Moreover, images with longer exposure showed weak α5(IV) chain immunostaining
in perivascular BMs from Col4a6 KO mice (S2 Fig). Similarly, α3(IV) and α4(IV) chains were
weakly immunopositive in the perivascular BMs (S2 Fig). Since collagen IV protomer assembly
requires three α(IV) chains, the lack of any one of these chains would result in a failure to
assemble a triple-helical form by the remaining two chains [8]. Collectively, our results suggest
that α1α2α1, α3α4α5, and α5α6α5 in the subepithelial and perivascular BMs, and α1α2α1 and
α3α4α5 in the perineural BMs contribute to the assembly of the collagen IV network. α5α6α5,
in addition to α1α2α1, is a quantitatively major component of the collagen IV network in the
perivascular BMs. Table 1 presents the tissue distribution of collagen IV in mouse cochlea.
Assessment of hearing threshold by click-evoked ABR
To assess the hearing function in Col4a6 KO mice, we compared the click-ABR thresholds of
WT mice to those of our Col4a6 KO mice (8-week-old male WT mice, C57BL/6J background).
The average threshold of the WT group and Col4a6 KO group were 40 ± 3.5 dB SPL and
43 ± 2.7 dB SPL, respectively (means ± SD, n = 5). The hearing threshold was not significantly
different between WT and Col4a6 KO mice (P = 0.172, Fig 4).
Fig 3. Distribution of collagen α5(IV) chain in the cochlea of WT and Col4a6 KO mice. (A, D–F) The collagen α5(IV) chain located in the
subepithelial BMs, perivascular BMs, and perineural BMs in WT mice (green). (B, G–I) In Col4a6 KO mice, the α5(IV) chain is widely
distributed (green). However, weak signals were detected in the perivascular BMs of the spiral limbus (SLim), spiral ligament (SLig), and stria
vascularis (SV) (dashed arrows). (C) No immunopositive signal of the collagen α6(IV) chain was present in Col4a6 KO mouse cochlea (green).
Nuclei were counterstained with Hoechst 33258 (blue). B, basilar membrane; RM, Reissner’s membrane; NF, neural fasciculus; SG, spiral
ganglion; IDC, interdental cells; ISC, inner sulcus cells; OSC, outer sulcus cells; RC, root cells; Cap, capillary. Scale bars = 50 μm.
https://doi.org/10.1371/journal.pone.0249909.g003
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Micro-CT analysis
Patients with hearing loss caused by the X-linked hereditary mutation of COL4A6 were
reported to have malformed cochlea, as determined using high-resolution CT [22]. Therefore,
Table 1. Qualitative assessment using immunohistochemistry: Distribution of collagen α1(IV), α2(IV), α5(IV), and α6(IV) chains and the predicted molecular
composition of the collagen IV network in mouse cochlea.
Classification¤ Location of BMs¤ α(IV) ¤ Predicted heterotrimer¤
α1a¤ α2a¤ α5a¤ α6b¤ α1α2α1a¤ α3α4α5a¤ α5α6α5b¤
Subepithelial BMs¤ Interdental cells¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Inner sulcus cells¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Basilar membrane¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Outer sulcus cells¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Root cells¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Reissner’s membrane¤ +¤ +¤ +¤ +¤ +¤ +¤ +¤
Perivascular BMs¤ Spiral limbus¤ +¤ +¤ +¤ +¤ +¤ +b¤ +¤
Spiral ligament¤ +¤ +¤ +¤ +¤ +¤ +b¤ +¤
Stria vascularis¤ +¤ +¤ +¤ +¤ +¤ +b¤ +¤
Perineural BMs¤ Neural fasciculus¤ +¤ +¤ +¤ -¤ +¤ +¤ -¤
Spiral ganglion¤ +¤ +¤ +¤ -¤ +¤ +¤ -¤
BM, Basement membrane; +, positive; -, negative.
a Its presence was previously identified [28, 30].
b Data shown for the first time in the current study. α3α4α5(IV) protomer in the perivascular BMs was a quantitatively minor component of the collagen IV network.
https://doi.org/10.1371/journal.pone.0249909.t001
Fig 4. Hearing threshold assessed by click-evoked auditory brainstem responses in WT and Col4a6 KO mice. No
significant difference observed between WT mice (mean 40 ± 3.5 dB SPL, n = 5) and Col4a6 KO mice (mean 43 ± 2.7
dB SPL, n = 5). P = 0.172 by Student’s unpaired t-tests. The values are presented as mean ± SD.
https://doi.org/10.1371/journal.pone.0249909.g004
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to investigate the structural abnormalities in Col4a6 KO mouse cochlea, we performed a
micro-CT analysis. No differences were observed in the three-dimensional images of the
petrous portion of the left temporal bone between the two groups of mice (Fig 5A). Moreover,
three kinds of orthogonal 2-D cross-sections, including the transverse plane (X-Y), sagittal
plane (Z-Y), and coronal plane (X-Z), were compared using DataViewer software. No abnor-
malities were found in the Col4a6 KO cochlea structure (Fig 5B–5G). Furthermore, the overlay
images based on the color map showed no differences in the size or shape of the cochlea
between WT and Col4a6 KO mice (Fig 5H–5K). Taken together, our results demonstrate that
Col4a6 KO mice have no gross malformation of the osseous labyrinth.
Fig 5. Comparison of the cochlea bone structure of WT and Col4a6 KO mice by micro-CT analysis. (A) Representative three-
dimensional images of the petrous portion of the left temporal bone in WT and Col4a6 KO mice. The top shows the apex of petrous in the
superior view. (B–G) The three orthogonal plane images were automatically obtained as a best-matched plane from the Col4a6 KO data set
compared to the images manually selected from the cochlea structure of the WT mice data set. (H–J) The overlay images demonstrated that
no differences in the size or shape are apparent in the cochlear bone between WT and Col4a6 KO mice. Blue squares represent the Volume of
Interest. (K) Light blue color indicates a highly matched degree based on the color map.
https://doi.org/10.1371/journal.pone.0249909.g005
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Histological analysis
To achieve a more detailed analysis of cochlear formation, both WT and Col4a6 KO (8-week-
old) mouse cochlea were compared histologically using HE-stained midmodiolar sections (Fig
6). Col4a6 KO mice exhibited regular morphological structures through the basal to apical
turn, as those observed in WT mice, comprising spiral limbus followed by inner sulcus, spiral
ganglion, and neural fasciculus extended to the organ of Corti, which adheres to the basilar
membrane (Fig 6A and 6B). Moreover, the tectorial membrane, spiral ligaments, stria vascu-
laris, and Reissner’s membrane were similar in structure between the two groups (Fig 6C and
6D). The outer and inner hair cell rows, accompanied by Dieter’s cells, also showed regular
morphology in Col4a6 KO and WT mice (Fig 6E and 6F). Hence, no significant differences in
any structure were detected in Col4a6 KO mice compared to WT mice (n = 3).
No change in the distribution of major BM components
To examine the changes in the expression of the other major BM components, we performed
immunohistochemistry. No apparent differences in the staining pattern of collagen α1(IV)
chain, perlecan, laminin α1, laminin α2, laminin γ1, or nidogen-1 were detected in the cochlea
of Col4a6 KO and WT mice (Fig 7).
Fig 6. Representative images of HE-stained midmodiolar cochlear sections. Histological comparison between WT
(A, C, E) and Col4a6 KO (B, D, F) mice. (C-F) Images with higher magnification of cochlear basal turn are shown. No
differences are observed between WT and Col4a6 KO mice. , basal turn; #, apical turn; SG, spiral ganglion; SLim, spiral
limbus; TM, tectorial membrane; B, Basilar membrane; Co, organ of Corti; SLig, spiral ligament; SV, stria vascularis;
RM, Reissner’s membrane; closed arrows, OHC (outer hair cells); arrows, IHC (inner hair cells); open arrowheads,
Dieter’s cells.
https://doi.org/10.1371/journal.pone.0249909.g006
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Discussion
In this study, we characterized the localization of the collagen α6(IV) chain in mouse cochlea
and demonstrated that the loss of collagen α6(IV) chain expression showed normal click ABR
thresholds and normal cochlear formation, which differs from humans with the COL4A6 mis-
sense mutation c.1771G>A, p.Gly591Ser.
Our results showed that the collagen α6(IV) chain is expressed in both subepithelial BMs in
the interdental cells, inner sulcus cells, basilar membrane, outer sulcus cells, root cells, and
Reissner’s membrane, as well as the perivascular BMs in the spiral limbus, spiral ligament, and
stria vascularis. A previous study reported that the α6(IV) chain exists intracellularly in a sub-
group of ganglia cells, while our results, using monoclonal antibody B66, did not detect signals
in these cells [22]. B66 has been established as a monoclonal antibody that specifically reacts
with the α6(IV) chain of human, bovine, and mice [9, 11, 32]. We reconfirmed that B66 had
no immunopositive signals in the tissue derived from Col4a6 KO mice (Fig 3C). In addition,
B66 showed clear immunopositive signals corresponding to the presence of BMs in the mouse
cochlea. On the other hand, the distribution of α3α4α5 in the cochlea of WT and Col4a3 KO
mice by immunohistochemistry using antibodies against collagen α3(IV), α4(IV), and α5(IV)
chains has been shown in previous reports [28, 30]. In this study, we presented immunohis-
tochemistry data using specific antibodies against each collagen α(IV) chain; hence, compari-
son of the distribution of collagen α1(IV) to α6(IV) chains represented the tissue-specific
collagen IV network of the mouse cochlea (Table 1). In particular, we demonstrated the pres-
ence of α1α2α1, α3α4α5, and α5α6α5 in subepithelial BMs, α1α2α1, α3α4α5, and α5α6α5 in
perivascular BMs, and α1α2α1 and α3α4α5 in perineural BMs.
Fig 7. Distribution of major basement membrane components in the cochlea of WT and Col4a6 KO mice. Cryosections were
immunostained by antibodies against collagen α1(IV) chain (A, B), perlecan (C, D), laminin α1 (E, F), laminin α2 (G, H), laminin γ1 (I, J),
and nidogen-1 (K, L). Nuclei were counterstained with Hoechst 33258 (blue). No differences are apparent between WT and Col4a6 KO mice.
Scale bars = 50 μm.
https://doi.org/10.1371/journal.pone.0249909.g007
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The stria vascularis is responsible for supporting the endocochlear potential and high potas-
sium content of the endolymph in the cochlear duct, which is necessary for sensory hair cell
conduction [33]. The structure comprises marginal cells, intermediate cells, basal cells, and a
dense capillary network. The capillaries and intermediate cells are located between the mar-
ginal cell layer and the basal cell layer. Moreover, the perivascular BMs surround the endothe-
lial cells and pericytes in the capillary network, which is contacted by the marginal cells and
intermediate cells [34]. BMs regulate various cell functions, such as stable anchoring, prolifera-
tion, and migration, primarily mediated by integrin, a major cell surface receptor for the extra-
cellular matrix. In addition, BMs serve as a filter for electrically charged molecules [5]. In fact,
perivascular BMs may participate in the blood-labyrinth barrier, which is essential for prevent-
ing the influx of harmful substances into the intrastrial space, similar to the blood-brain barrier
[35, 36]. Moreover, double-layered BMs are detected in the stria vascularis, which are derived
from endothelial cells, pericytes, and marginal and intermediate epithelial cells [34, 37]. Hear-
ing impairment that is age-related, drug-induced, or results from acute injury or genetic dis-
ease, such as Alport syndrome (AS), is associated with changes in the structure and
components of the perivascular BMs in the stria vascularis [28, 38–41]. Interestingly, the colla-
gen α6(IV) chain was detected in the outer layer of BMs surrounding the capillary network of
the stria vascularis, suggesting that the α6(IV) chain-containing BMs may functionally be
related to marginal and intermediate epithelial cells.
Recently, a Hungarian family was reported to have congenital X-linked nonsyndromic
hearing loss caused by a mutation in COL4A6 (c.1771G>A, p.Gly591Ser), which was accom-
panied by cochlear malformation. All male members of this family with the COL4A6 mutation
showed severe-to-profound hearing loss at all frequencies tested (0.125 to 8 kHz), which began
during early childhood. Bioinformatic analysis showed that this mutation produces an atypical
large side-chain in the interchain of the heterotrimer, which reduces the stability of the triple-
helix and likely triggers disarrangement of the quaternary structure [22]. However, the current
study demonstrates that the click ABR thresholds, histology, and micro-CT scanning images
of Col4a6 KO mice did not differ compared to those of WT mice. We also examined the possi-
bility that other BM components compensated for the deleterious effect induced by the
absence of the collagen α6(IV) chain in the cochlea. However, immunohistochemistry staining
showed that the expression of major BM components did not differ between Col4a6 KO and
WT mice. Taken together, our results suggest that a null-type mutation of Col4a6 in mice had
no deleterious impact on cochlear formation or on click ABR thresholds. Our characterization
of the Col4a6 KO mice differs dramatically from the phenotype observed in humans with the
COL4A6 missense mutation c.1771G>A, p.Gly591Ser.
Collagens constitute a superfamily of extracellular matrix proteins that function primarily
as structural proteins. Several collagen genes (COL1A1, COL1A2, COL2A1, COL4A3, COL4A4,
COL4A5, COL11A1, and COL11A2) are associated with hereditary syndromic hearing loss.
Mutations in COL11A1 and COL11A2 have been shown to cause nonsyndromic hereditary
hearing loss [42, 43]. Osteogenesis imperfecta (OI) is commonly caused by autosomal domi-
nant mutations in the genes encoding collagen I and is characterized by growth deficiency and
vulnerability to fractures from minimal trauma [44]. The molecular defect in type I OI, the
mildest form, is a null COL1A1 allele caused by frameshifts or a premature stop codon, result-
ing in reduced synthesis of structurally normal collagen, whereas types II–IV OI, the more
severe forms, are caused by defects in the collagen I fibril structure, most commonly glycine
substitutions (80%). The mutated collagen α(I) chain delays the folding of the heterotrimer
and results in over-post-translational modification. Misfolded heterotrimers then induce the
unfolded protein response (UPR) in the endoplasmic reticulum, associated with a pathogenic
defect in the differentiation and maturation of osteoblasts. In cases where abnormal
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procollagen can escape from the intracellular degradation pathway and are secreted, the colla-
gen fiber with a misfolded heterotrimer has lower integrity and affects the mechanical strength
and various cell-matrix interactions [45]. Moreover, AS is a hereditary disorder characterized
by progressive renal failure, sensorineural hearing loss, and ocular defects caused by mutations
in COL4A3, COL4A4, and COL4A5. To date, over 500 mutations have been identified, includ-
ing point mutations, deletions, and insertions of a large or small nucleotide sequence [46–49].
Most mutations result in failure of assembly and/or secretion of collagen α3α4α5(IV) hetero-
trimers, and consequently, all three α chains are missing from the tissue. While collagen
α3α4α5(IV) heterotrimers with subtle missense mutations can be assembled, secreted, and
form the network in some cases; however, it still results in milder disease severity in patients
due to the functionally impaired BMs [48]. For instance, Naito et al. showed sparse or normal
immunostained signals of the collagen α5(IV) chains harboring the glycine substituted mis-
sense mutation in the glomerular BM of patients [50]. Of note, a missense mutation, COL4A3-
G1334E, leads to collagen α3α4α5(IV) heterotrimer misfolding, which causes podocyte UPR
[51]. Besides, chemical chaperones have recently been reported to have therapeutic potential
for AS by normalizing the mutated collagen α3α4α5(IV) heterotrimer [52].
Collectively, the missense mutation of COL4A6 (c.1771G>A, p.Gly591Ser) may affect hear-
ing impairment as a consequence of the aberrant function associated with the collagen α6(IV)
chain due to a misfolded collagen heterotrimer (Fig 1). Although the present study was not
designed to show the direct effect of the mutated collagen α6(IV) chain on hearing function,
our findings might provide a basis for developing advanced applications of a Col4a6 knock-in
mouse model carrying the missense mutation. Further studies are necessary to elucidate the
pathogenesis of hereditary hearing loss and cochlear malformation associated with COL4A6
missense mutations.
The primary limitation of this study is that the analysis of hearing levels in mice was exclu-
sively based on the click-ABR method, which does not provide information on the frequency-
specific hearing levels. Hearing assessment in our future studies will include ABR using pure
tones to analyze hearing levels in low, middle, and high frequencies. Moreover, although the
present study detected no histological differences in the organ of Corti between WT and
Col4a6 KO mice, via light microscopy, Col4a6 KO mice may have BM functional impairment
of the organ of Corti along the tonotopic axis of the apical, middle, and basal cochlear turns,
which are involved in sound transduction at each frequency. In addition, startle response test-
ing will provide insight into behavioral responses to brief, intense sound and otoacoustic emis-
sions testing will further evaluate the function of outer hair cells along the tonotopic axis of the
cochlea.
Supporting information
S1 Fig. Distribution of collagen α1(IV) and α2(IV) chains in the mouse cochlea. Cryosec-
tions were immunostained with antibodies against α1(IV) (A–F: green) and α2(IV) chains
(G–L: green). Nuclei were counterstained with Hoechst 33258 (blue). SLim, spiral limbus; NF,
neural fasciculus; SG, spiral ganglion; B, basilar membrane; SLig, spiral ligament; SV, stria vas-
cularis; RM, Reissner’s membrane. Scale bars = 50 μm.
(TIF)
S2 Fig. Distribution of collagen α3(IV), α4(IV), and α5(IV) chains in the perivascular
basement membranes of WT and Col4a6 KO mice. Cryosections were immunostained with
antibodies against α3(IV) (A: green), α4(IV) (B: green), α5(IV) chains (C–F: green), and CD31
(D–F: red). The results suggest that α3α4α5(IV) heterotrimer is present in the perivascular
BMs of the mouse cochlea. (A–C) The subepithelial BMs in the spiral ligament (SLig) were
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used as positive controls for each antibody in the inset. (G–I) The negative control was estab-
lished by immunostaining with only secondary antibody; no specific reaction was observed.
Nuclei were counterstained with Hoechst 33258 (blue). Arrows, immunopositive perivascular
BMs in the spiral ligament (SLig); open arrowheads, immunopositive perivascular BMs in the
stria vascularis (SV); SLim, spiral limbus. Scale bars = 50 μm. Scale bars in inset = 20 μm.
(TIF)
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Dr. Reinhard Fässler (Max Planck Institute of Biochemistry) for the support in generating
knockout mice.
Author Contributions
Conceptualization: Tomoko Yonezawa, Toshitaka Oohashi.
Formal analysis: Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Mitsuaki Ono, Toru
Miyoshi, Ryusuke Momota.
Funding acquisition: Tomoko Yonezawa, Toshitaka Oohashi.
Investigation: Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Takahiro Maeba.
Methodology: Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Mitsuaki Ono.
Project administration: Tomoko Yonezawa.
Resources: Tomoko Yonezawa, Yukihide Maeda, Mitsuaki Ono, Toru Miyoshi, Yasuko
Tomono, Toshitaka Oohashi.
Supervision: Toru Miyoshi, Ryusuke Momota, Yasuko Tomono, Toshitaka Oohashi.
Validation: Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Mitsuaki Ono, Takahiro
Maeba, Toru Miyoshi, Ryusuke Momota, Yasuko Tomono, Toshitaka Oohashi.
Writing – original draft: Shaoying Tang, Tomoko Yonezawa.
Writing – review & editing: Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Toru
Miyoshi, Ryusuke Momota, Toshitaka Oohashi.
References
1. Fuchs JC, Tucker AS. Development and Integration of the Ear. Curr Top Dev Biol. 2015; 115: 213–32.
https://doi.org/10.1016/bs.ctdb.2015.07.007 PMID: 26589927
2. Ekdale EG. Form and function of the mammalian inner ear. J Anat. 2016; 228(2): 324–37. https://doi.
org/10.1111/joa.12308 PMID: 25911945
3. Peeleman N, Verdoodt D, Ponsaerts P, Van Rompaey V. On the Role of Fibrocytes and the Extracellu-
lar Matrix in the Physiology and Pathophysiology of the Spiral Ligament. Front Neurol. 2020; 11:
580639. https://doi.org/10.3389/fneur.2020.580639 PMID: 33193034
4. Jung J, Yoo JE, Choe YH, Park SC, Lee HJ, Lee HJ, et al. Cleaved Cochlin Sequesters Pseudomonas
aeruginosa and Activates Innate Immunity in the Inner Ear. Cell Host Microbe. 2019; 25(4): 513–25.e6.
https://doi.org/10.1016/j.chom.2019.02.001 PMID: 30905438
5. Pozzi A, Yurchenco PD, Iozzo RV. The nature and biology of basement membranes. Matrix Biol.
2017;57–58: 1–11. https://doi.org/10.1016/j.matbio.2016.10.006 PMID: 27751945
PLOS ONE Hearing in Col4a6 knockout mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0249909 April 13, 2021 14 / 17
6. Sado Y, Kagawa M, Naito I, Ueki Y, Seki T, Momota R, et al. Organization and expression of basement
membrane collagen IV genes and their roles in human disorders. J Biochem. 1998; 123(5): 767–76.
https://doi.org/10.1093/oxfordjournals.jbchem.a022003 PMID: 9562604
7. Khoshnoodi J, Pedchenko V, Hudson BG. Mammalian collagen IV. Microsc Res Tech. 2008; 71(5):
357–70. https://doi.org/10.1002/jemt.20564 PMID: 18219669
8. Brown KL, Cummings CF, Vanacore RM, Hudson BG. Building collagen IV smart scaffolds on the out-
side of cells. Protein Sci. 2017; 26(11): 2151–61. https://doi.org/10.1002/pro.3283 PMID: 28845540
9. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, et al. Differential expression of two base-
ment membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence stain-
ing using peptide-specific monoclonal antibodies. J Cell Biol. 1995; 130(5): 1219–29. https://doi.org/10.
1083/jcb.130.5.1219 PMID: 7657706
10. Seki T, Naito I, Oohashi T, Sado Y, Ninomiya Y. Differential expression of type IV collagen isoforms,
alpha5(IV) and alpha6(IV) chains, in basement membranes surrounding smooth muscle cells. Histo-
chem Cell Biol. 1998; 110(4): 359–66. https://doi.org/10.1007/s004180050296 PMID: 9792414
11. Saito K, Naito I, Seki T, Oohashi T, Kimura E, Momota R, et al. Differential expression of mouse alpha5
(IV) and alpha6(IV) collagen genes in epithelial basement membranes. Journal of biochemistry. 2000;
128(3): 427–34. https://doi.org/10.1093/oxfordjournals.jbchem.a022770 PMID: 10965041
12. Borza DB, Bondar O, Ninomiya Y, Sado Y, Naito I, Todd P, et al. The NC1 domain of collagen IV
encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth mus-
cle basement membranes. J Biol Chem. 2001; 276(30): 28532–40. https://doi.org/10.1074/jbc.
M103690200 PMID: 11375996
13. Urabe N, Naito I, Saito K, Yonezawa T, Sado Y, Yoshioka H, et al. Basement membrane type IV colla-
gen molecules in the choroid plexus, pia mater and capillaries in the mouse brain. Arch Histol Cytol.
2002; 65(2): 133–43. https://doi.org/10.1679/aohc.65.133 PMID: 12164337
14. Hasegawa H, Naito I, Nakano K, Momota R, Nishida K, Taguchi T, et al. The distributions of type IV col-
lagen alpha chains in basement membranes of human epidermis and skin appendages. Arch Histol
Cytol. 2007; 70(4): 255–65. https://doi.org/10.1679/aohc.70.255 PMID: 18296826
15. Saito K, Yonezawa T, Minaguchi J, Kurosaki M, Suetsugu S, Nakajima A, et al. Distribution of alpha(IV)
collagen chains in the ocular anterior segments of adult mice. Connective tissue research. 2011; 52(2):
147–56. https://doi.org/10.3109/03008207.2010.492062 PMID: 20672978
16. Oohashi T, Sugimoto M, Mattei MG, Ninomiya Y. Identification of a new collagen IV chain, alpha 6(IV),
by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for
COL4A5. J Biol Chem. 1994; 269(10): 7520–6. PMID: 8125972
17. Zhou J, Ding M, Zhao Z, Reeders ST. Complete primary structure of the sixth chain of human basement
membrane collagen, alpha 6(IV). Isolation of the cDNAs for alpha 6(IV) and comparison with five other
type IV collagen chains. J Biol Chem. 1994; 269(18): 13193–9. PMID: 8175748
18. Fox MA, Sanes JR, Borza DB, Eswarakumar VP, Fassler R, Hudson BG, et al. Distinct target-derived
signals organize formation, maturation, and maintenance of motor nerve terminals. Cell. 2007; 129(1):
179–93. https://doi.org/10.1016/j.cell.2007.02.035 PMID: 17418794
19. Murata T, Katayama K, Oohashi T, Jahnukainen T, Yonezawa T, Sado Y, et al. COL4A6 is dispensable
for autosomal recessive Alport syndrome. Sci Rep. 2016; 6: 29450. https://doi.org/10.1038/srep29450
PMID: 27377778
20. Komori T, Ono M, Hara ES, Ueda J, Nguyen HTT, Nguyen HT, et al. Type IV collagen alpha6 chain is a
regulator of keratin 10 in keratinization of oral mucosal epithelium. Sci Rep. 2018; 8(1): 2612. https://
doi.org/10.1038/s41598-018-21000-0 PMID: 29422532
21. Takeuchi M, Yamaguchi S, Yonemura S, Kakiguchi K, Sato Y, Higashiyama T, et al. Type IV Collagen
Controls the Axogenesis of Cerebellar Granule Cells by Regulating Basement Membrane Integrity in
Zebrafish. PLoS Genet. 2015; 11(10): e1005587. https://doi.org/10.1371/journal.pgen.1005587 PMID:
26451951
22. Rost S, Bach E, Neuner C, Nanda I, Dysek S, Bittner RE, et al. Novel form of X-linked nonsyndromic
hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6.
Eur J Hum Genet. 2014; 22(2): 208–15. https://doi.org/10.1038/ejhg.2013.108 PMID: 23714752
23. Kohda T, Okada S, Hayashi A, Kanzaki S, Ninomiya Y, Taki M, et al. High nephritogenicity of monoclo-
nal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int. 2004; 66
(1): 177–86. https://doi.org/10.1111/j.1523-1755.2004.00719.x PMID: 15200424
24. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, et al. Recombinant nidogen con-
sists of three globular domains and mediates binding of laminin to collagen type IV. Embo j. 1991; 10
(11): 3137–46. PMID: 1717261
PLOS ONE Hearing in Col4a6 knockout mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0249909 April 13, 2021 15 / 17
25. Maeda Y, Fukushima K, Omichi R, Kariya S, Nishizaki K. Time courses of changes in phospho- and
total- MAP kinases in the cochlea after intense noise exposure. PLoS One. 2013; 8(3): e58775. https://
doi.org/10.1371/journal.pone.0058775 PMID: 23484051
26. Maeda Y, Kariya S, Omichi R, Noda Y, Sugaya A, Fujimoto S, et al. Targeted PCR Array Analysis of
Genes in Innate Immunity and Glucocorticoid Signaling Pathways in Mice Cochleae Following Acoustic
Trauma. Otol Neurotol. 2018; 39(7): e593–e600. https://doi.org/10.1097/MAO.0000000000001874
PMID: 29995014
27. Khattab HM, Ono M, Sonoyama W, Oida Y, Shinkawa S, Yoshioka Y, et al. The BMP2 antagonist inhibi-
tor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism. Bone.
2014; 69: 165–73. https://doi.org/10.1016/j.bone.2014.09.011 PMID: 25240457
28. Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, et al. Ultrastructural, physiologi-
cal, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syn-
drome. Hear Res. 1998; 121(1–2): 84–98. https://doi.org/10.1016/s0378-5955(98)00069-0 PMID:
9682811
29. Tsuprun V, Santi P. Proteoglycan arrays in the cochlear basement membrane. Hear Res. 2001; 157(1–
2): 65–76. https://doi.org/10.1016/s0378-5955(01)00278-7 PMID: 11470186
30. Cosgrove D, Samuelson G, Pinnt J. Immunohistochemical localization of basement membrane colla-
gens and associated proteins in the murine cochlea. Hear Res. 1996; 97(1–2): 54–65. PMID: 8844186
31. Shodo R, Hayatsu M, Koga D, Horii A, Ushiki T. Three-dimensional reconstruction of root cells and
interdental cells in the rat inner ear by serial section scanning electron microscopy. Biomed Res. 2017;
38(4): 239–48. https://doi.org/10.2220/biomedres.38.239 PMID: 28794401
32. Sado Y, Kagawa M, Kishiro Y, Sugihara K, Naito I, Seyer JM, et al. Establishment by the rat lymph node
method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human
type IV collagen. Histochem Cell Biol. 1995; 104(4): 267–75. https://doi.org/10.1007/BF01464322
PMID: 8548560
33. Hibino H, Nin F, Tsuzuki C, Kurachi Y. How is the highly positive endocochlear potential formed? The
specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch.
2010; 459(4): 521–33. https://doi.org/10.1007/s00424-009-0754-z PMID: 20012478
34. Takeuchi S, Ando M, Sato T, Kakigi A. Three-dimensional and ultrastructural relationships between
intermediate cells and capillaries in the gerbil stria vascularis. Hear Res. 2001; 155(1–2): 103–12.
https://doi.org/10.1016/s0378-5955(01)00252-0 PMID: 11335080
35. Yonezawa T, Ohtsuka A, Yoshitaka T, Hirano S, Nomoto H, Yamamoto K, et al. Limitrin, a novel immu-
noglobulin superfamily protein localized to glia limitans formed by astrocyte endfeet. Glia. 2003; 44(3):
190–204. https://doi.org/10.1002/glia.10279 PMID: 14603461
36. Yonezawa T, Hattori S, Inagaki J, Kurosaki M, Takigawa T, Hirohata S, et al. Type IV collagen induces
expression of thrombospondin-1 that is mediated by integrin alpha1beta1 in astrocytes. Glia. 2010; 58
(7): 755–67. https://doi.org/10.1002/glia.20959 PMID: 20091789
37. Suzuki M, Sakamoto T, Kashio A, Yamasoba T. Age-related morphological changes in the basement
membrane in the stria vascularis of C57BL/6 mice. Eur Arch Otorhinolaryngol. 2016; 273(1): 57–62.
https://doi.org/10.1007/s00405-014-3478-4 PMID: 25555607
38. Meehan DT, Delimont D, Dufek B, Zallocchi M, Phillips G, Gratton MA, et al. Endothelin-1 mediated
induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice.
Hear Res. 2016; 341: 100–8. https://doi.org/10.1016/j.heares.2016.08.003 PMID: 27553900
39. Pakdaman MN, Ishiyama G, Ishiyama A, Peng KA, Kim HJ, Pope WB, et al. Blood-Labyrinth Barrier
Permeability in Menière Disease and Idiopathic Sudden Sensorineural Hearing Loss: Findings on
Delayed Postcontrast 3D-FLAIR MRI. AJNR Am J Neuroradiol. 2016; 37(10): 1903–8. https://doi.org/
10.3174/ajnr.A4822 PMID: 27256854
40. Shi X. Pathophysiology of the cochlear intrastrial fluid-blood barrier (review). Hear Res. 2016; 338: 52–
63. https://doi.org/10.1016/j.heares.2016.01.010 PMID: 26802581
41. Ishiyama G, Lopez IA, Ishiyama P, Vinters HV, Ishiyama A. The blood labyrinthine barrier in the human
normal and Meniere’s disease macula utricle. Sci Rep. 2017; 7(1): 253. https://doi.org/10.1038/s41598-
017-00330-5 PMID: 28325925
42. McGuirt WT, Prasad SD, Griffith AJ, Kunst HP, Green GE, Shpargel KB, et al. Mutations in COL11A2
cause non-syndromic hearing loss (DFNA13). Nat Genet. 1999; 23(4): 413–9. https://doi.org/10.1038/
70516 PMID: 10581026
43. Booth KT, Askew JW, Talebizadeh Z, Huygen PLM, Eudy J, Kenyon J, et al. Splice-altering variant in
COL11A1 as a cause of nonsyndromic hearing loss DFNA37. Genet Med. 2019; 21(4): 948–54. https://
doi.org/10.1038/s41436-018-0285-0 PMID: 30245514
PLOS ONE Hearing in Col4a6 knockout mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0249909 April 13, 2021 16 / 17
44. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteo-
genesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations
align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007; 28(3): 209–21.
https://doi.org/10.1002/humu.20429 PMID: 17078022
45. Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev
Endocrinol. 2011; 7(9): 540–57. https://doi.org/10.1038/nrendo.2011.81 PMID: 21670757
46. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correla-
tion in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002; 17(7):
1218–27. https://doi.org/10.1093/ndt/17.7.1218 PMID: 12105244
47. Hashimura Y, Nozu K, Kaito H, Nakanishi K, Fu XJ, Ohtsubo H, et al. Milder clinical aspects of X-linked
Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int. 2014; 85(5): 1208–13.
https://doi.org/10.1038/ki.2013.479 PMID: 24304881
48. Funk SD, Lin MH, Miner JH. Alport syndrome and Pierson syndrome: Diseases of the glomerular base-
ment membrane. Matrix Biol. 2018. https://doi.org/10.1016/j.matbio.2018.04.008 PMID: 29673759
49. Rheault MN, Savige J, Randles MJ, Weinstock A, Stepney M, Turner AN, et al. The importance of clini-
cian, patient and researcher collaborations in Alport syndrome. Pediatr Nephrol. 2020; 35(5): 733–42.
https://doi.org/10.1007/s00467-019-04241-7 PMID: 31044288
50. Naito I, Kawai S, Nomura S, Sado Y, Osawa G. Relationship between COL4A5 gene mutation and dis-
tribution of type IV collagen in male X-linked Alport syndrome. Japanese Alport Network. Kidney Int.
1996; 50(1): 304–11. https://doi.org/10.1038/ki.1996.316 PMID: 8807602
51. Pieri M, Stefanou C, Zaravinos A, Erguler K, Stylianou K, Lapathitis G, et al. Evidence for activation of
the unfolded protein response in collagen IV nephropathies. J Am Soc Nephrol. 2014; 25(2): 260–75.
https://doi.org/10.1681/ASN.2012121217 PMID: 24262798
52. Omachi K, Kamura M, Teramoto K, Kojima H, Yokota T, Kaseda S, et al. A Split-Luciferase-Based Tri-
mer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome.
Cell Chem Biol. 2018; 25(5): 634–43.e4. https://doi.org/10.1016/j.chembiol.2018.02.003 PMID:
29526710
PLOS ONE Hearing in Col4a6 knockout mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0249909 April 13, 2021 17 / 17
